Irving Wainer - Academia.edu (original) (raw)
Papers by Irving Wainer
Clinical Pharmacology & Therapeutics, 1996
ABSTRACT
Drug Metabolism and Disposition, Jul 1, 2000
Cancer Research, Jun 15, 1990
Chromatographia, 1992
ABSTRACT
Current Opinion in Drug Discovery Development, Feb 1, 2002
The effect of disease state on drug metabolism has been investigated using the relationship betwe... more The effect of disease state on drug metabolism has been investigated using the relationship between genotype and metabolic phenotype. The two polymorphic probes, N-acetyltransferases-2 (NAT2) and cytochrome P450 2C19 (CYP2C19), were respectively used in HIV+/AIDS patients and patients with advanced cancer. The results of the studies suggest that advanced disease produces discordances between genotype and phenotype, indicating a reduction in the metabolic capabilities of these individuals. Thus, polymorphic enzymes such as CYP2C19 and NAT2 can be used to probe changes in drug-metabolizing enzyme capacities. The development of genotype/phenotype discordances should reflect general changes in metabolic capabilities and, thus, alterations in the activities of other important enzymes such as CYP3A. The data also suggest that the genotype/phenotype probes can be used to optimize the clinical treatment of patients with advanced disease states.
The Faseb Journal, Mar 1, 2008
Hrc Cc Journal of High Resolution Chromatography Chromatography Communications, 1984
Journal of Chromatography a, May 21, 1982
Circulation, Oct 28, 2008
Journal of Chromatography a, Oct 1, 1986
Journal of Chromatography a, 1983
Journal of Chromatography a, Jun 1, 1985
Journal of Chromatography a, 1983
Journal of Liquid Chromatography, 1986
Page 1. JOURNAL OF LIQUID CHROMATOGRAPHY, 9(2&3), 455-471 (1986) THE APPLICAT... more Page 1. JOURNAL OF LIQUID CHROMATOGRAPHY, 9(2&3), 455-471 (1986) THE APPLICATION OF HPLC CHIRAL STATIONARY PHASES TO STEREOCHEMICAL PROBLEMS OF PHARMACEUTICAL INTEREST: A GENERAL METHOD FOR THE RESOLUTION ...
Clinical Pharmacology & Therapeutics, 1996
ABSTRACT
Drug Metabolism and Disposition, Jul 1, 2000
Cancer Research, Jun 15, 1990
Chromatographia, 1992
ABSTRACT
Current Opinion in Drug Discovery Development, Feb 1, 2002
The effect of disease state on drug metabolism has been investigated using the relationship betwe... more The effect of disease state on drug metabolism has been investigated using the relationship between genotype and metabolic phenotype. The two polymorphic probes, N-acetyltransferases-2 (NAT2) and cytochrome P450 2C19 (CYP2C19), were respectively used in HIV+/AIDS patients and patients with advanced cancer. The results of the studies suggest that advanced disease produces discordances between genotype and phenotype, indicating a reduction in the metabolic capabilities of these individuals. Thus, polymorphic enzymes such as CYP2C19 and NAT2 can be used to probe changes in drug-metabolizing enzyme capacities. The development of genotype/phenotype discordances should reflect general changes in metabolic capabilities and, thus, alterations in the activities of other important enzymes such as CYP3A. The data also suggest that the genotype/phenotype probes can be used to optimize the clinical treatment of patients with advanced disease states.
The Faseb Journal, Mar 1, 2008
Hrc Cc Journal of High Resolution Chromatography Chromatography Communications, 1984
Journal of Chromatography a, May 21, 1982
Circulation, Oct 28, 2008
Journal of Chromatography a, Oct 1, 1986
Journal of Chromatography a, 1983
Journal of Chromatography a, Jun 1, 1985
Journal of Chromatography a, 1983
Journal of Liquid Chromatography, 1986
Page 1. JOURNAL OF LIQUID CHROMATOGRAPHY, 9(2&3), 455-471 (1986) THE APPLICAT... more Page 1. JOURNAL OF LIQUID CHROMATOGRAPHY, 9(2&3), 455-471 (1986) THE APPLICATION OF HPLC CHIRAL STATIONARY PHASES TO STEREOCHEMICAL PROBLEMS OF PHARMACEUTICAL INTEREST: A GENERAL METHOD FOR THE RESOLUTION ...